enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Lenalidomide - Wikipedia

    en.wikipedia.org/wiki/Lenalidomide

    Lenalidomide, sold under the brand name Revlimid among others, is a medication used to treat multiple myeloma, smoldering myeloma, and myelodysplastic syndromes (MDS). [8] For multiple myeloma, it is a first line treatment, and is given with dexamethasone . [ 8 ]

  3. Cereblon E3 ligase modulator - Wikipedia

    en.wikipedia.org/wiki/Cereblon_E3_ligase_modulator

    The thalidomide molecule is a synthetic derivative of glutamic acid and consists of a glutarimide ring and a phthaloyl ring (Figure 5). [15] [16] Its IUPAC name is 2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione and it has one chiral center [15] After thalidomide's selective inhibition of TNF-α had been reported, a renewed effort was put in thalidomide's clinical development.

  4. Chemotherapy regimen - Wikipedia

    en.wikipedia.org/wiki/Chemotherapy_regimen

    non-Hodgkin lymphoma: RdC lenalidomide (Revlimid), dexamethasone, cyclophosphamide: AL amyloidosis R-Benda rituximab + bendamustine: follicular lymphoma and MALT lymphoma [7] R-DHAP or DHAP-R: rituximab + DHAP; that is, rituximab, dexamethasone (a steroid hormone), cytarabine (ara-C), platinum agent: relapsed non-Hodgkin's lymphoma and Hodgkin ...

  5. Oral Anti-Cancer Therapy REVLIMID® (lenalidomide) Now ... - AOL

    www.aol.com/2013/06/17/oral-anti-cancer-therapy...

    Oral Anti-Cancer Therapy REVLIMID ® (lenalidomide) Now Indicated as a Treatment for Patients with Rare Form of Blood Disease Treatment indicated for patients with transfusion-dependent anaemia ...

  6. Myelodysplastic syndrome - Wikipedia

    en.wikipedia.org/wiki/Myelodysplastic_syndrome

    [24] [25] By 2005, lenalidomide, a chemotherapy drug, was recognized to be effective in MDS patients with the 5q- syndrome, [26] and in December 2005, the US FDA approved the drug for this indication. Patients with isolated 5q-, low IPSS risk, and transfusion dependence respond best to lenalidomide. Typically, prognosis for these patients is ...

  7. Revlimid Gains, Celgene Loses - AOL

    www.aol.com/news/2013-06-05-celgene-gains-new...

    Celgene announced good news today about its blockbuster drug Revlimid. Did the stock jump as a result? Nope. Shares actually fell by more than 4%. Here's what happened. Good newsThe U.S. Food and ...

  8. NYT ‘Connections’ Hints and Answers Today, Sunday ... - AOL

    www.aol.com/nyt-connections-hints-answers-today...

    Get ready for all of today's NYT 'Connections’ hints and answers for #553 on Sunday, December 15, 2024. Today's NYT Connections puzzle for Sunday, December 15, 2024The New York Times.

  9. The use of rituximab has been established for the treatment of B-cell–derived hematologic malignancies, including follicular lymphoma (FL) and diffuse large B-cell lymphoma (DLBCL). [ 7 ] In addition to cure-directed treatment, people can benefit from self-care to manage symptoms.